Vasorin deficiency leads to cardiac hypertrophy by targeting MYL7 in young mice.
Sun J, Guo X, Yu P, Liang J, Mo Z, Zhang M, Yang L, Huang X, Hu B, Liu J, Ouyang Y, He M.
Sun J, et al.
J Cell Mol Med. 2022 Jan;26(1):88-98. doi: 10.1111/jcmm.17034. Epub 2021 Dec 2.
J Cell Mol Med. 2022.
PMID: 34854218
Free PMC article.
The aim of this research was to ascertain whether VASN induces pathological cardiac hypertrophy by targeting myosin light chain 7 (MYL7). VASN(-/-) mice were produced by CRISPR/Cas9 technology and inbreeding. ...Our results revealed a pathological phenomenon in which VASN …
The aim of this research was to ascertain whether VASN induces pathological cardiac hypertrophy by targeting myosin light chain 7 (MYL7 …